Literature DB >> 20020000

Where physicians look for information on drug prescribing for children.

Doreen M Matsui1, Mary Elizabeth Jardine, Erin Steer, Victoria Cukernik, Michael J Rieder.   

Abstract

BACKGROUND: Despite the important role of drug therapy in children, there is often a lack of readily available information regarding the indications and dosing regimens for medications in paediatrics.
OBJECTIVE: To collect data on where family physicians obtain this prescribing information.
METHOD: A structured questionnaire was mailed to 500 family physicians in Ontario.
RESULTS: Questionnaires were returned by 261 (52%) family physicians, 217 (83%) of whom identified themselves as currently involved in the care of children. Most (87%) reported that the Compendium of Pharmaceuticals and Specialties (CPS) was the source that they most commonly consulted for drug information in children. The available sources of information on prescribing for children were thought to be not adequate by 40% and not readily available by 27%. Sixty-one per cent reported being moderately confident (in doubt part of the time) about their decisions regarding drug prescribing in this age group. The majority (70%) had learned most of what they know about prescribing in paediatrics during practice, while 69% and 62% reported they had little or no teaching during undergraduate and postgraduate (internship or residency) medical education, respectively.
CONCLUSIONS: Although it is recognized that for a number of drugs used in children the CPS does not reflect the current standard of care in paediatrics, it is currently the source most commonly referred to by family physicians. Further work should be done in the provision of useful information on paediatric drug therapy to family physicians.

Entities:  

Keywords:  Children; Family physicians; Prescribing

Year:  2003        PMID: 20020000      PMCID: PMC2792647          DOI: 10.1093/pch/8.4.219

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  7 in total

1.  Off-label uses of drugs in children.

Authors:  J L Blumer
Journal:  Pediatrics       Date:  1999-09       Impact factor: 7.124

2.  Unlicensed and off label prescribing of drugs in general practice.

Authors:  J McIntyre; S Conroy; A Avery; H Corns; I Choonara
Journal:  Arch Dis Child       Date:  2000-12       Impact factor: 3.791

3.  Testing medications in children.

Authors:  Robert Steinbrook
Journal:  N Engl J Med       Date:  2002-10-31       Impact factor: 91.245

4.  Uses of drugs not described in the package insert (off-label uses).

Authors: 
Journal:  Pediatrics       Date:  2002-07       Impact factor: 7.124

5.  Reported adverse drug events in infants and children under 2 years of age.

Authors:  Thomas J Moore; Sheila R Weiss; Sigal Kaplan; Carol J Blaisdell
Journal:  Pediatrics       Date:  2002-11       Impact factor: 7.124

6.  Unlicensed and off-label drug use: issues and recommendations.

Authors:  Sharon Conroy
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

7.  The use of newly marketed drugs in children and adolescents prescribed in general practice.

Authors:  L V Wilton; G Pearce; R D Mann
Journal:  Pharmacoepidemiol Drug Saf       Date:  1999-04       Impact factor: 2.890

  7 in total
  2 in total

Review 1.  A literature review on off-label drug use in children.

Authors:  Chiara Pandolfini; Maurizio Bonati
Journal:  Eur J Pediatr       Date:  2005-05-24       Impact factor: 3.183

2.  Medications for Children: A Survey of Community Pharmacists.

Authors:  Alina R Rashid; Mark Duffett
Journal:  J Pediatr Pharmacol Ther       Date:  2016 May-Jun
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.